JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MTVA
4301
MetaVia Inc
MTVA
$10.1M
| – | – |
0
| – | – |
2017 Q2
0 quarters
|
|
|
GLCN
4302
DELISTED
VanEck China Growth Leaders ETF
GLCN
| $21K | ﹤0.01% |
+500
| New | +$19.8K |
2017 Q2
0 quarters
|
|
|
ATTO
4303
DELISTED
Atento S.A.
ATTO
| $21K | ﹤0.01% |
+378
| New | +$18.8K |
2017 Q2
0 quarters
|
|
|
ACSF
4304
DELISTED
American Capital Senior Floating, Ltd.
ACSF
| $21K | ﹤0.01% |
1,650
-861
| -34% | -$11.4K |
2016 Q3
3 quarters
|
|
|
KITE
4305
CALL
DELISTED
Kite Pharma, Inc.
KITE
| $21K | ﹤0.01% |
200
-43,100
| -100% | -$3.52M |
2017 Q1
1 quarter
|
|
|
BXE
4306
DELISTED
Bellatrix Exploration Ltd.
BXE
| $21K | ﹤0.01% |
+7,207
| New | +$25.1K |
2017 Q2
0 quarters
|
|
4307
InfraCap MLP ETF
AMZA
$461M
| $20K | ﹤0.01% |
+200
| New | +$20.4K |
2017 Q2
0 quarters
|
|
4308
Aptevo Therapeutics
APVO
$3.19M
| – | – |
0
| – | – |
2017 Q2
0 quarters
|
|
|
ETX
4309
Eaton Vance Municipal Income 2028 Term Trust
ETX
$191M
| $20K | ﹤0.01% |
1,000
| – | – |
2017 Q1
1 quarter
|
|
4310
iShares Residential and Multisector Real Estate ETF
REZ
$789M
| $20K | ﹤0.01% |
300
| – | – |
2016 Q1
5 quarters
|
|
4311
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.42B
| $20K | ﹤0.01% |
400
-6,466
| -94% | -$327K |
2016 Q4
2 quarters
|
|
4312
Tenet Healthcare
THC
$20.8B
| $20K | ﹤0.01% |
1,039
-283
| -21% | -$4.94K |
2013 Q2
16 quarters
|
|
|
ALIM
4313
DELISTED
Alimera Sciences
ALIM
| $20K | ﹤0.01% |
+940
| New | +$20.1K |
2017 Q2
0 quarters
|
|
|
PRGX
4314
DELISTED
PRGX Global, Inc.
PRGX
| $20K | ﹤0.01% |
+3,100
| New | +$19.9K |
2017 Q2
0 quarters
|
|
|
FRED
4315
DELISTED
Fred's Inc
FRED
| $20K | ﹤0.01% |
2,209
+315
| +17% | +$4.18K |
2016 Q4
2 quarters
|
|
|
NXTM
4316
DELISTED
NxStage Medical Inc.
NXTM
| $20K | ﹤0.01% |
780
+110
| +16% | +$2.72K |
2016 Q4
2 quarters
|
|
|
ALOT
4317
DELISTED
AstroNova
ALOT
| $19K | ﹤0.01% |
+1,456
| New | +$20.8K |
2017 Q2
0 quarters
|
|
4318
Precigen
PGEN
$3.06B
| $19K | ﹤0.01% |
784
-28,768
| -97% | -$631K |
2013 Q3
15 quarters
|
|
|
PAMT
4319
PAMT Corp
PAMT
$256M
| $19K | ﹤0.01% |
4,092
-3,344
| -45% | -$14.5K |
2016 Q4
2 quarters
|
|
|
CIR
4320
DELISTED
CIRCOR International, Inc
CIR
| $19K | ﹤0.01% |
327
-23,654
| -99% | -$1.48M |
2016 Q4
2 quarters
|
|
|
SIR
4321
DELISTED
SELECT INCOME REIT
SIR
| $19K | ﹤0.01% |
1,786
+253
| +17% | +$2.76K |
2016 Q4
2 quarters
|
|
|
JONE
4322
DELISTED
Jones Energy, Inc.
JONE
| $19K | ﹤0.01% |
597
-10,427
| -95% | -$421K |
2014 Q3
11 quarters
|
|
|
STDY
4323
DELISTED
SteadyMed Ltd
STDY
| $19K | ﹤0.01% |
+2,981
| New | +$20.3K |
2017 Q2
0 quarters
|
|
4324
First Bancorp
FNLC
$386M
| $18K | ﹤0.01% |
664
-6,243
| -90% | -$165K |
2015 Q4
6 quarters
|
|
|
SGMO
4325
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $18K | ﹤0.01% |
1,990
-9,756
| -83% | -$62.6K |
2016 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.